companydata.dkcompanydata.dk

Nordic-Neurostim ApS: Financial statements 2022

CVR: 38049909

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Nordic-Neurostim ApS (CVR 38049909) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -561,752 and a net result of DKK -454,342 compared with DKK -1,098,410 the year before. Equity in the 2022 report amounted to DKK -1,666,147.

Gross Profit
DKK -561,752
Profit/Loss
DKK -454,342
Equity
DKK -1,666,147
Total Assets
DKK 1,337,492

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--562K-454K-1.7M-
2021--1.4M-1.1M-1.2M-
2020--1.1M-927K-113K-
2019-33K-16K117K-
2018-249K184K132K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Nordic-Neurostim ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Nordic-Neurostim ApS: The 2021 annual report is outMay 20, 2022

Nordic-Neurostim ApS has published its annual report for 2021. Gross profit came to DKK -1,390,077, and the net result was DKK -1,098,410.

About Nordic-Neurostim ApS

Nordic-Neurostim ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christian Peter Christiansen. The board consists of Morten Kristian Haugland (chair) and Christian Peter Christiansen. The company is owned by MORTEN HAUGLAND HOLDING ApS, Varebex ApS and Medodan Consulting ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 89,658 and a net result of DKK -33,430 compared with DKK -10,264 the year before. Equity in the 2025 report amounted to DKK -1,858,514.

Source: annual report 2025, Danish Business Authority

Other financial years